# Safety of Juvista When Administered Following Excision of Ear Lobe Keloids

> **NCT00710333** · PHASE1,PHASE2 · COMPLETED · sponsor: **Renovo** · enrollment: 10 (estimated)

## Conditions studied

- Keloid

## Interventions

- **DRUG:** Avotermin
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00710333
- **Lead sponsor:** Renovo
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-07
- **Primary completion:** 2009-10
- **Final completion:** 2009-12
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2010-03-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00710333

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00710333, "Safety of Juvista When Administered Following Excision of Ear Lobe Keloids". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00710333. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*